Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liewei Wang

Showing results (261-270 of 277) with videos related to

Pageof 28
Sort By:
Signal Transduction and Targeted Therapy|May 10, 2023
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumorsChao Zhang, Qiang Guo, Lifeng Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.
Nature Medicine|August 15, 2017
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4Xiangpeng Dai, Wenjian Gan, Xiaoning Li, et al.
International Journal of Cancer|June 24, 2015
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto studyAlexander Hein, Diether Lambrechts, Gunter von Minckwitz, et al.
Breast Cancer Research : BCR|December 8, 2017
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer studyJia Yu, Bo Qin, Ann M Moyer, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Breast Cancer Research : BCR|March 26, 2021
Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer studyJia Yu, Bo Qin, Ann M Moyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2022
Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast CancerPeter A Fasching, Duan Liu, Steve Scully, et al.
Journal of the National Cancer Institute|April 5, 2017
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast CancerMatthew P Goetz, Krishna R Kalari, Vera J Suman, et al.
Breast Cancer Research and Treatment|August 23, 2015
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapyMarissa S Ellingson, Steven N Hart, Krishna R Kalari, et al.
Pageof 28

Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Signal Transduction and Targeted Therapy|May 10, 2023
A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumorsChao Zhang, Qiang Guo, Lifeng Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.
Nature Medicine|August 15, 2017
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4Xiangpeng Dai, Wenjian Gan, Xiaoning Li, et al.
International Journal of Cancer|June 24, 2015
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto studyAlexander Hein, Diether Lambrechts, Gunter von Minckwitz, et al.
Breast Cancer Research : BCR|December 8, 2017
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer studyJia Yu, Bo Qin, Ann M Moyer, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Breast Cancer Research : BCR|March 26, 2021
Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer studyJia Yu, Bo Qin, Ann M Moyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2022
Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast CancerPeter A Fasching, Duan Liu, Steve Scully, et al.
Journal of the National Cancer Institute|April 5, 2017
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast CancerMatthew P Goetz, Krishna R Kalari, Vera J Suman, et al.
Breast Cancer Research and Treatment|August 23, 2015
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapyMarissa S Ellingson, Steven N Hart, Krishna R Kalari, et al.
Pageof 28